NCT03459404View on ClinicalTrials.gov

Sufentanil NanoTab PCA System/15 mcg for Acute Post-Operative Pain in Vertebral Surgery: A Preliminary Investigation

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

March 10, 2019

Study Completion Date

March 10, 2019

Conditions
Postoperative PainSpinal FusionSpondylolisthesis, Lumbar RegionSufentanil
Interventions
COMBINATION_PRODUCT

Sufentanil NanoTab PCA System

15 mcg Sufentanil NanoTab self-administered sublingually up to every 20 minutes as needed for pain for at least 48 hours and up to 72 hours

Trial Locations (1)

00168

Policlinico A. Gemelli, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT03459404 - Sufentanil NanoTab PCA System/15 mcg for Acute Post-Operative Pain in Vertebral Surgery: A Preliminary Investigation | Biotech Hunter | Biotech Hunter